PASG — Passage Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Passage Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	305	316	190	114	76.8
Prepaid Expenses
Total Current Assets	317	325	197	118	78.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.79	23.8	42.2	32.2	23.1
Other Long Term Assets
Total Assets	328	355	244	151	102
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	21.2	29.5	18.4	16.3	19.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	23.3	36.4	42.2	39.3	41.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	305	319	201	111	61.3
Total Liabilities & Shareholders' Equity	328	355	244	151	102
Total Common Shares Outstanding